30 May 2019
International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera
www.twobirds.com/en/news/press-releases/2019/uk/international-team-advises-chiesi-farmaceutici-on-inlicence-of-raxone-from-santhera

International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")

18 April 2019
Bird & Bird Germany advises Aphria on its tender for the cultivation, processing and delivery of cannabis for medical purposes
www.twobirds.com/en/news/press-releases/2019/germany/bird-bird-beraet-aphria-im-vergabeverfahren-cannabis

We have advised Aphria Deutschland GmbH on its tender for the cultivation, processing and delivery of cannabis for medical purposes.

10 June 2020
Our Life Sciences team is named Regulatory Firm of the Year at the LMG European Life Sciences Awards 2020
www.twobirds.com/en/news/press-releases/2020/global/our-life-sciences-team-is-named-regulatory-firm-of-the-year-at-the-lmg-european-life-sciences-awards

We are delighted to announce that our Life Sciences team has won two awards at the 8th annual LMG European Life Sciences Awards 2020.